Fredric N Eshelman - Net Worth and Insider Trading
Fredric N Eshelman Net Worth
The estimated net worth of Fredric N Eshelman is at least $191 Million dollars as of 2024-04-25. Fredric N Eshelman is the Executive Chairman of The Medicines Co and owns about 2,072,920 shares of The Medicines Co (MDCO) stock worth over $176 Million. Fredric N Eshelman is the Director, 10% Owner of G1 Therapeutics Inc and owns about 3,689,151 shares of G1 Therapeutics Inc (GTHX) stock worth over $14 Million. Fredric N Eshelman is also the Director, 10% Owner of Eyenovia Inc and owns about 1,273,428 shares of Eyenovia Inc (EYEN) stock worth over $905,789. Details can be seen in Fredric N Eshelman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Fredric N Eshelman has not made any transactions after 2018-01-29 and currently still holds the listed stock(s).
Transaction Summary of Fredric N Eshelman
Fredric N Eshelman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fredric N Eshelman owns 8 companies in total, including Aravive Inc (ARAV) , Eyenovia Inc (EYEN) , and Liquidia Corp (LQDA) among others .
Click here to see the complete history of Fredric N Eshelman’s form 4 insider trades.
Insider Ownership Summary of Fredric N Eshelman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARAV | Aravive Inc | 2020-04-08 | director |
EYEN | Eyenovia Inc | 2020-09-11 | director |
LQDA | Liquidia Corp | 2020-11-19 | 10 percent owner |
GTHX | G1 Therapeutics Inc | 2017-11-13 | director & 10 percent owner |
AMHCU | Amplitude Healthcare Acquisition Corp | 2019-11-19 | director |
MDCO | The Medicines Co | 2018-05-31 | director & Executive Chairman |
BHC | Bausch Health Companies Inc | 2016-03-08 | director |
JSPR | Jasper Therapeutics Inc | 2019-11-19 | director |
Fredric N Eshelman Latest Holdings Summary
Fredric N Eshelman currently owns a total of 3 stocks. Among these stocks, Fredric N Eshelman owns 2,072,920 shares of The Medicines Co (MDCO) as of December 8, 2017, with a value of $176 Million and a weighting of 92.08%. Fredric N Eshelman owns 3,689,151 shares of G1 Therapeutics Inc (GTHX) as of November 13, 2017, with a value of $14 Million and a weighting of 7.45%. Fredric N Eshelman also owns 1,273,428 shares of Eyenovia Inc (EYEN) as of January 29, 2018, with a value of $905,789 and a weighting of 0.47%.
Latest Holdings of Fredric N Eshelman
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MDCO | The Medicines Co | 2017-12-08 | 2,072,920 | 84.90 | 175,990,908 |
GTHX | G1 Therapeutics Inc | 2017-11-13 | 3,689,151 | 3.86 | 14,240,123 |
EYEN | Eyenovia Inc | 2018-01-29 | 1,273,428 | 0.71 | 905,789 |
Holding Weightings of Fredric N Eshelman
Fredric N Eshelman Form 4 Trading Tracker
According to the SEC Form 4 filings, Fredric N Eshelman has made a total of 0 transactions in The Medicines Co (MDCO) over the past 5 years. The most-recent trade in The Medicines Co is the acquisition of 200,000 shares on December 8, 2017, which cost Fredric N Eshelman around $5 Million.
According to the SEC Form 4 filings, Fredric N Eshelman has made a total of 0 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years. The most-recent trade in G1 Therapeutics Inc is the acquisition of 250,000 shares on November 13, 2017, which cost Fredric N Eshelman around $5 Million.
According to the SEC Form 4 filings, Fredric N Eshelman has made a total of 0 transactions in Eyenovia Inc (EYEN) over the past 5 years. The most-recent trade in Eyenovia Inc is the acquisition of 335,000 shares on January 29, 2018, which cost Fredric N Eshelman around $3 Million.
Insider Trading History of Fredric N Eshelman
- 1
Fredric N Eshelman Trading Performance
GuruFocus tracks the stock performance after each of Fredric N Eshelman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fredric N Eshelman is 13.74%. GuruFocus also compares Fredric N Eshelman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fredric N Eshelman within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fredric N Eshelman's insider trading performs compared to the benchmark.
Performance of Fredric N Eshelman
Average Return
41.13%
Outperforming Transactions
50%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 3.06 | 13.74 | 32.71 | 41.13 | 7.2 | 1.9 |
Relative Return to S&P 500(%) | 2.21 | 11.51 | 27.57 | 33.66 | -2.46 | -8.43 |
Fredric N Eshelman Ownership Network
Ownership Network List of Fredric N Eshelman
Ownership Network Relation of Fredric N Eshelman
Fredric N Eshelman Owned Company Details
What does Aravive Inc do?
Who are the key executives at Aravive Inc?
Fredric N Eshelman is the director of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .
Aravive Inc (ARAV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aravive Inc Insider Transactions
Fredric N Eshelman Mailing Address
Above is the net worth, insider trading, and ownership report for Fredric N Eshelman. You might contact Fredric N Eshelman via mailing address: Ppd Inc, 929 North Front Street, Wilmington Nc 28401.